MODULATION DER EXPRESSION VON DIACYLGLYCERIN-ACYLTRANSFERASE 2
European patent · EP1664271 · Deleted
Register entry
- Publication number
- EP1664271
- Application number
- EP04779444
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Aug 18, 2004
- Published
- Jun 7, 2006
- Granted
- Jun 8, 2011
- Deleted
- Mar 23, 2023
- Reason
- Annual fee unpaid
- IPC classes
- C12N 15/11 (2006.01)C07H 21/04 (2006.01)
- Priority
- US 643801 18.08.2003
- PCT application
- PCT/US2004/024384 18.08.2004
- PCT publication
- WO2005/019418 03.03.2005
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Mar 23, 2023
Deleted, fee unpaid
Published in Swissreg on 23.03.2023
- Sep 22, 2021
Address changed
- Owner
- ISIS PHARMACEUTICALS, INC., 2292 Faraday Avenue, Carlsbad, CA 92008, USA → Isis Pharmaceuticals, Inc., 2855 Gazelle Court, Carlsbad, CA 92010, USA
Published in Swissreg on 22.09.2021
- Jun 23, 2011
Agent entered
- Representative
- E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich
Published in Swissreg on 23.06.2011
- Jun 8, 2011
Granted
Published in Swissreg on 08.06.2011
Parties
Holder
Inventor
BHANOT, Sanjay
Carlsbad, CA 92009, US
DOBIE, Kenneth, W.
Del Mar, CA 92014, US
YU, Xing-Xian
San Diego, CA 92130, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.